Clinical Trial Update: Pilot Study: Lipoic Acid and Omega-3 Fatty Acids for Alzheimer's Prevention [Phase 1, Phase 2]

View source ↗

Summary

A Phase 1/2 pilot study evaluating alpha-lipoic acid and omega-3 fatty acids for Alzheimer's prevention has completed, with results posted in 2017.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Alzheimer Disease
• Hypertension

Drugs mentioned

• Alpha Lipoic Acid (alpha-lipoic acid)
• Omega-3 fatty acids (omega-3 fatty acids)

Snippet

Sponsor: Oregon Health and Science University | Conditions: Treated Hypertension | Phase 1, Phase 2 | Status: COMPLETED | Results posted: 2017-04-07